| abstract |
(57) [Summary]n(A) Formoterol or a pharmaceutically acceptable salt thereof, or a solvate of formoterol or a solvate of the salt thereof, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airway disease. And (B) mometasone furoate separately or simultaneously. |